Publication | Open Access
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
19
Citations
14
References
2025
Year
European Commission H2020 Programme; French Health Ministry PHRC2014; and Motor Neurone Disease Association.
| Year | Citations | |
|---|---|---|
Page 1
Page 1